InventisBio Co Ltd

688382

Company Profile

  • Business description

    InventisBio Co Ltd is an innovative drug research and development enterprise based in China with a global perspective, focusing on major diseases such as tumors and metabolic diseases. It has independently developed a series of innovative targeted drugs with patent protection, covering non-small cell lung cancer, breast cancer, colorectal cancer and other solid tumors, as well as hyperuricemia and metabolic diseases such as gout.

  • Contact

    No. 4, Lane 67, Li Bing Road
    Room 210
    Pilot Free Trade Zone
    Shanghai201203
    CHN

    T: +86 2150778527

    http://www.inventisbio.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    185

Stocks News & Analysis

stocks

Undervalued ASX share showing progress in global efforts

More clarity on the path forward in the UK.
stocks

Bookworm: Is this the secret to exceptional long-term returns?

Acceptance may be an investor’s best friend.
stocks

Unconventional wisdom: Are dividends the answers?

As investors toil in complexity the obvious solution may be the right one.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,959.9025.600.29%
CAC 407,834.5816.300.21%
DAX 4024,217.5078.43-0.32%
Dow JONES (US)44,901.92208.010.47%
FTSE 1009,120.3118.06-0.20%
HKSE25,526.59138.240.54%
NASDAQ21,108.3250.360.24%
Nikkei 22541,141.20315.03-0.76%
NZX 50 Index12,949.9696.500.75%
S&P 5006,388.6425.290.40%
S&P/ASX 2008,694.1027.200.31%
SSE Composite Index3,598.154.490.12%

Market Movers